Literature DB >> 28823810

EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.

Judith L Thijs1, Julia Drylewicz2, Renée Fiechter1, Ian Strickland3, Matthew A Sleeman3, Athula Herath3, Richard D May3, Catharina A F M Bruijnzeel-Koomen4, Edward F Knol1, Barbara Giovannone4, Marjolein S de Bruin-Weller4, Stefan Nierkens5, Dirk Jan Hijnen6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28823810     DOI： 10.1016/j.jaci.2017.06.046

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  8 in total

Review 1.  Severe Atopic Dermatitis in Children.

Authors:  Evie Huang; Peck Y Ong
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-10       Impact factor: 4.806

2.  Blueprint for mechanistic, data-rich early phase clinical pharmacology studies in dermatology.

Authors:  Robert Rissmann; Matthijs Moerland; Martijn B A van Doorn
Journal:  Br J Clin Pharmacol       Date:  2020-04-06       Impact factor: 4.335

Review 3.  Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council.

Authors:  Kilian Eyerich; Sara J Brown; Bethany E Perez White; Reiko J Tanaka; Robert Bissonette; Sandipan Dhar; Thomas Bieber; Dirk J Hijnen; Emma Guttman-Yassky; Alan Irvine; Jacob P Thyssen; Christian Vestergaard; Thomas Werfel; Andreas Wollenberg; Amy S Paller; Nick J Reynolds
Journal:  J Allergy Clin Immunol       Date:  2018-11-07       Impact factor: 10.793

Review 4.  Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.

Authors:  Matthew Moyle; Ferda Cevikbas; Jamie L Harden; Emma Guttman-Yassky
Journal:  Exp Dermatol       Date:  2019-04-15       Impact factor: 3.960

5.  EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.

Authors:  Daphne S Bakker; Lieneke F M Ariens; Barbara Giovannone; DirkJan Hijnen; Eveline M Delemarre; Edward Knol; Stefan Nierkens; Marjolein S de Bruin-Weller; Judith L Thijs; Julia Drylewicz
Journal:  Allergy       Date:  2020-07-24       Impact factor: 13.146

6.  Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe disease.

Authors:  Jonathan T Sims; Ching-Yun Chang; Richard E Higgs; Sarah M Engle; Yushi Liu; Sean E Sissons; George H Rodgers; Eric L Simpson; Jonathan I Silverberg; Seth B Forman; Jonathan M Janes; Stephanie C Colvin; Emma Guttman-Yassky
Journal:  Exp Dermatol       Date:  2021-06-09       Impact factor: 4.511

Review 7.  Atopic Dermatitis: Striving for Reliable Biomarkers.

Authors:  Styliani Mastraftsi; Georgia Vrioni; Michail Bakakis; Electra Nicolaidou; Dimitrios Rigopoulos; Alexander J Stratigos; Stamatios Gregoriou
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

8.  Multispectral raster-scanning optoacoustic mesoscopy differentiate lesional from non-lesional atopic dermatitis skin using structural and functional imaging markers.

Authors:  Xiuting Li; Mohesh Moothanchery; Cheng Yi Kwa; Wan Ling Tan; Yik Weng Yew; Steven Tien Guan Thng; U S Dinish; Amalina Binte Ebrahim Attia; Malini Olivo
Journal:  Photoacoustics       Date:  2022-08-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.